Zomedica Announces Second Quarter 2020 Financial Results
10 août 2020 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company, today reported consolidated financial...
Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability
07 août 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (“Zomedica”) (NYSE American: ZOM), a veterinary health company, announced that Robert Cohen, Interim Chief...
Zomedica Announces Management Change
03 août 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (“Zomedica”) (NYSE American: ZOM) (TSX-V: ZOM), a veterinary health company, announced that Shameze Rampertab has...
Successful Remote Installation of TRUFORMA™
21 juil. 2020 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., July 21, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company, announced today that, in response...
Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering
07 juil. 2020 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., July 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the closing of...
Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering
01 juil. 2020 22h30 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing...
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
01 juil. 2020 16h04 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, announced today that it has...
Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch
16 juin 2020 18h05 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 16, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (“Zomedica” or the “Company”) (NYSE American: ZOM), a veterinary diagnostic company, announced that it has...
Zomedica Pharmaceuticals Corp. Closes $20 Million Public Offering
29 mai 2020 16h05 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 29, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the closing of...
Zomedica Pharmaceuticals Corp. Announces $20 Million Public Offering
26 mai 2020 22h16 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of...